Go Pro
→ Buy this stock today (From Chaikin Analytics) (Ad)tc pixel Free ACONW Stock Alerts

Aclarion (ACONW) Competitors

Aclarion logo
$0.02 0.00 (-1.36%)
As of 03:37 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

ACONW vs. DHACW, LFMDP, PIIIW, TALKW, and TOIIW

Should you buy Aclarion stock or one of its competitors? MarketBeat compares Aclarion with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aclarion include Digital Health Acquisition (DHACW), LifeMD (LFMDP), P3 Health Partners (PIIIW), Talkspace (TALKW), and Oncology Institute (TOIIW). These companies are all part of the "healthcare" industry.

How does Aclarion compare to Digital Health Acquisition?

Aclarion (NASDAQ:ACONW) and Digital Health Acquisition (NASDAQ:DHACW) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, profitability, analyst recommendations, risk, valuation and dividends.

Company Net Margins Return on Equity Return on Assets
AclarionN/A N/A N/A
Digital Health Acquisition N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aclarion$77.88KN/AN/AN/AN/A
Digital Health AcquisitionN/AN/AN/AN/AN/A

In the previous week, Aclarion's average media sentiment score of 0.00 equaled Digital Health Acquisition'saverage media sentiment score.

Company Overall Sentiment
Aclarion Neutral
Digital Health Acquisition Neutral

Summary

Aclarion beats Digital Health Acquisition on 1 of the 1 factors compared between the two stocks.

How does Aclarion compare to LifeMD?

LifeMD (NASDAQ:LFMDP) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

Company Net Margins Return on Equity Return on Assets
LifeMDN/A N/A N/A
Aclarion N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeMD$193.33MN/AN/AN/AN/A
Aclarion$77.88KN/AN/AN/AN/A

In the previous week, LifeMD had 1 more articles in the media than Aclarion. MarketBeat recorded 1 mentions for LifeMD and 0 mentions for Aclarion. LifeMD's average media sentiment score of 0.00 equaled Aclarion'saverage media sentiment score.

Company Overall Sentiment
LifeMD Neutral
Aclarion Neutral

Summary

LifeMD beats Aclarion on 2 of the 2 factors compared between the two stocks.

How does Aclarion compare to P3 Health Partners?

P3 Health Partners (NASDAQ:PIIIW) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability.

Company Net Margins Return on Equity Return on Assets
P3 Health PartnersN/A N/A N/A
Aclarion N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
P3 Health Partners$1.47BN/AN/AN/AN/A
Aclarion$77.88KN/AN/AN/AN/A

In the previous week, P3 Health Partners' average media sentiment score of 0.00 equaled Aclarion'saverage media sentiment score.

Company Overall Sentiment
P3 Health Partners Neutral
Aclarion Neutral

Summary

P3 Health Partners beats Aclarion on 1 of the 1 factors compared between the two stocks.

How does Aclarion compare to Talkspace?

Aclarion (NASDAQ:ACONW) and Talkspace (NASDAQ:TALKW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, media sentiment, analyst recommendations, institutional ownership and risk.

Company Net Margins Return on Equity Return on Assets
AclarionN/A N/A N/A
Talkspace N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aclarion$77.88KN/AN/AN/AN/A
Talkspace$238.37MN/AN/AN/AN/A

In the previous week, Aclarion's average media sentiment score of 0.00 equaled Talkspace'saverage media sentiment score.

Company Overall Sentiment
Aclarion Neutral
Talkspace Neutral

Summary

Talkspace beats Aclarion on 1 of the 1 factors compared between the two stocks.

How does Aclarion compare to Oncology Institute?

Oncology Institute (NASDAQ:TOIIW) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

Company Net Margins Return on Equity Return on Assets
Oncology InstituteN/A N/A N/A
Aclarion N/A N/A N/A

In the previous week, Oncology Institute's average media sentiment score of 0.00 equaled Aclarion'saverage media sentiment score.

Company Overall Sentiment
Oncology Institute Neutral
Aclarion Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oncology Institute$545.76MN/AN/AN/AN/A
Aclarion$77.88KN/AN/AN/AN/A

Summary

Oncology Institute beats Aclarion on 1 of the 1 factors compared between the two stocks.

Get Aclarion News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACONW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACONW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACONW vs. The Competition

Export
MetricAclarionHealth Information Services IndustryMedical SectorNASDAQ Exchange
Market CapN/A$1.04B$6.81B$12.41B
Dividend YieldN/A6.04%2.67%9.39%
P/E RatioN/A301.2127.0024.19
Price / SalesN/A133.90518.8494.59
Price / CashN/A47.1426.6847.25
Price / BookN/A7.1010.676.26
Net IncomeN/A-$22.78M$3.60B$331.76M
7 Day PerformanceN/A-2.44%-0.37%-1.10%
1 Month PerformanceN/A-1.91%1.85%-1.27%
1 Year PerformanceN/A-11.27%25.51%18.85%

Aclarion Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACONW
Aclarion
N/A$0.02
-1.4%		N/A-38.0%$0.00$77.88KN/A7
DHACW
Digital Health Acquisition
N/A$0.02
flat		N/AN/A$0.00N/AN/AN/A
LFMDP
LifeMD
N/A$23.46
+0.5%		N/A-1.4%$0.00$193.33MN/A230
PIIIW
P3 Health Partners
N/A$0.01
-7.4%		N/A+28.7%$0.00$1.47BN/A500
TALKW
Talkspace
N/A$0.00
flat		N/AN/A$0.00$238.37MN/A500

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:ACONW) was last updated on 7/21/2026 by MarketBeat.com Staff.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel